Spineway designs, produces, and sells spinal column implants and surgical instruments. The group offers spinal systems, cervical and lumbar cages, cervical plates, bone substitutes, etc. Net sales are distributed geographically as follows: France (24.4%), Europe (16.9%), Latin America (34.3%), Asia (18.2%) and the Middle East and Africa (6.2%).

Employees

Sector

Medical Equipment, Supplies & Distribution

Calendar

Earnings release - Q2 2026

More about the company

Market Cap	2.79M 3.19M 2.57M 2.39M 4.53M 304M 4.59M 30.78M 11.98M 149M 11.97M 11.71M 517M	P/E 2026 *	-2x	P/E 2027 *	-2x
Enterprise Value	9.29M 10.61M 8.56M 7.94M 15.08M 1.01B 15.29M 102M 39.87M 497M 39.84M 38.97M 1.72B	EV / Sales 2026 *	0.7x	EV / Sales 2027 *	0.98x
Free-Float	9.65%	Yield 2026 *	-	Yield 2027 *	-

04-30	Spineway SA Reports Unaudited Consolidated Revenue Results for the First Quarter of 2026	CI
02-17	Spineway SA Reports Earnings Results for the Full Year Ended December 31, 2025	CI
02-16	Zonebourse Company Earnings Calendar: February 17, 2026
01-14	Spineway Sa Announces Revenue Results for Second Half and Full Year 2025	CI
14/10/25	Spineway SA Reports Unaudited Consolidated Revenue Results for the Third Quarter and Nine Months of 2025	CI
30/07/25	Spineway SA Reports Earnings Results for the Half Year Ended June 30, 2025	CI
24/03/25	Spineway SA Reports Earnings Results for the Full Year Ended December 31, 2024	CI
19/12/24	Spineway Secures Approvals in Vietnam for Certain Product Lines	MT
18/12/24	Spineway Wins New Approvals in Vietnam and Registers Initial Orders	CI
15/10/24	Spineway SA Reports Unaudited consolidated Revenue Results for the Third Quarter and Nine Months of 2024	CI
23/09/24	Spineway SA Reports Earnings Results for the Half Year Ended June 30, 2024	CI
16/07/24	Spineway: growth slows, share price falls
15/07/24	Spineway Reports Unaudited Revenue Results for the Second Quarter and First Half of 2023	CI

04-30	Spineway : First-quarter 2026 revenue	AQ
04-07	SPINEWAY : Minutes of the General Meeting of April 2, 2026	PU
02-17	Spineway : 2025 annual results	AQ
01-13	SPINEWAY : 2025 revenue of €12.4 million, with an acceleration of sales in Q4 2025 (+34%)	AQ
14/10/25	Spineway : Revenue growth in the third quarter	AQ

04-30	SPINEWA : SPINEWAY
04-07	SPINEWAY : Compte-rendu de l’Assemblée Générale du 2 avril 2026
02-17	SPINEWAY : Résultats annuels 2025
02-16	Agenda Zonebourse des résultats de sociétés : le 17 février 2026
01-13	Bourse : Sika et Lindt publient, Alphabet taille 4 000, Airbus dans les clous

Manager	Title	Age	Since
Stéphane Le Roux CEO	Chief Executive Officer	65	28/09/2005
Erwan Martin DFI	Director of Finance/CFO	-	01/11/2024

Spineway SA Stock Euronext Paris

Stocks

FR001400N2P2

Medical Equipment, Supplies & Distribution

Valuation: Spineway SA

Latest news : Spineway SA

Press Releases: Spineway SA

News in other languages: Spineway SA

Managers and Directors: Spineway SA

Other Medical Equipment, Supplies & Distribution

Financials

Company Profile

Director	Title	Age	Since
Stéphane Le Roux CHM	Chairman	65	28/09/2005
Joseph Brigneaud BRD	Director/Board Member	48	13/10/2017
Bérangère Boggio BRD	Director/Board Member	46	26/04/2016

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SPINEWAY SA	-.--%	-.--%	-	-	3.33M
ABBOTT LABORATORIES	+0.24%	+1.60%	-28.87%	-10.93%	166B
MEDTRONIC PLC	-0.16%	+2.57%	-6.03%	-4.39%	106B
CENCORA, INC.	+0.69%	+4.34%	+0.78%	+56.60%	57.69B
HOYA CORPORATION	-1.37%	0.00%	+53.74%	+52.32%	53.78B
BECTON, DICKINSON AND COMPANY	-1.61%	-0.24%	-11.71%	-40.25%	43.56B
MEDLINE INC.	-1.02%	+9.98%	-	-	36.52B
DEXCOM, INC.	+1.59%	+3.19%	-12.72%	-43.48%	27.49B
WEST PHARMACEUTICAL SERVICES, INC.	-2.21%	+1.94%	+60.91%	-5.14%	25.84B
STERIS PLC	-2.25%	-1.11%	-10.22%	-2.58%	21.27B
Average	-0.45%	+4.67%	+5.74%	+0.27%	59.87B
Weighted average by Cap.	-0.49%	+3.80%	-3.99%	+1.31%

	2026 *	2027 *
Net sales	13.2M 15.07M 12.16M 11.29M 21.43M 1.44B 21.72M 146M 56.64M 706M 56.6M 55.36M 2.45B	14.5M 16.56M 13.36M 12.4M 23.54M 1.58B 23.86M 160M 62.22M 775M 62.18M 60.81M 2.69B
Net income	-2.5M -2.85M -2.3M -2.14M -4.06M -272M -4.11M -27.56M -10.73M -134M -10.72M -10.48M -463M	-2.5M -2.85M -2.3M -2.14M -4.06M -272M -4.11M -27.56M -10.73M -134M -10.72M -10.48M -463M
Net Debt	6.5M 7.42M 5.99M 5.56M 10.55M 708M 10.7M 71.67M 27.89M 348M 27.87M 27.26M 1.2B	11.4M 13.02M 10.5M 9.75M 18.51M 1.24B 18.76M 126M 48.92M 609M 48.88M 47.81M 2.11B